Dong-A to enter "sibutramine" anti-obesity drug markets

Published: 2007-09-04 06:59:00

Updated: 2007-09-04 06:59:00

Dong-A is going to launch Shranker capsule (sibutramine), an anti-obesity drug, into the markets. Shranker means a "shrink" in German, implying the reduction of a wait size and body fats.

Shranker was formulated with sibutramine without salt, showing its safety and bio-equivalency by clinical ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK